We are doing science for policy
The Joint Research Centre (JRC) is the European Commission's science and knowledge service which employs scientists to carry out research in order to provide independent scientific advice and support to EU policy.
The European Commission today issued a Communication in response to the European Citizens’ Initiative Stop Vivisection.
Female liver cells, and in particular those in menopaused women, are more susceptible to adverse effects of drugs than their male counterparts, according to new research carried out by the JRC.
The JRC has validated and recommended a new method which is not based on animal testing, to identify chemicals that can trigger skin allergies, estimated to affect already 20% of the population in Europe.
In support of EU legislation on safety of chemicals, the JRC has published a state-of-the art review of test methods and non-testing (computational) approaches that help promote the replacement, reduction, and refinement of animal experiments - known as the 3Rs - in the safety assessment of chemicals. The report "Alternative methods for regulatory toxicology – a state-of-the-art review" focuses on "non-standard" methods, i.e. those that are not included in current regulatory guidelines.
The JRC has launched an online tool to identify chemicals useful for the development and validation of alternative methods to animal testing.
A JRC team today receives the first Lush Science Prize for their pioneering work on non-animal chemical safety testing at an awards ceremony in London.